Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions
Nikolaos Alexandris, George Lagoumintzis, Christos T. Chasapis, et al.
Toxicology Reports (2020) Vol. 8, pp. 73-83
Open Access | Times Cited: 60

Showing 26-50 of 60 citing articles:

Protecting effects of smoking against COVID-19: a community-based retrospective cohort study in middle- and older-aged adults
Xiaomeng Hou, Fulin Zheng, Likun Lu, et al.
Internal and Emergency Medicine (2024) Vol. 19, Iss. 8, pp. 2141-2149
Open Access | Times Cited: 1
In Silico Development of SARS-CoV-2 Non-covalent Mpro Inhibitors: A Review
Islam Alagawani, Feng Wang
(2024)
Open Access | Times Cited: 1
Impact of COVID-19 acute respiratory disease on the risk factors attributed to cancer patients
Elena Lak, Mohammad Javad Mohammadi, Homayon Yousefi
Toxicology Reports (2021) Vol. 9, pp. 46-52
Open Access | Times Cited: 8
Research Progress in the Pharmacological Effects and Synthesis of Nicotine
Xiaoping Ye, Yanxin Zhang, Xiaoping Song, et al.
ChemistrySelect (2022) Vol. 7, Iss. 12
Closed Access | Times Cited: 6
Nornicotine-typed insecticides: The potential insecticides with strong activity against Diaphorina citri
Pengfei Hu, Xiaoping Ye, Xiaoping Song, et al.
Advanced Agrochem (2023) Vol. 2, Iss. 2, pp. 180-184
Open Access | Times Cited: 3
Inflammatory reflex disruption in COVID‐19
Khalil Hajiasgharzadeh, Mahdi Jafarlou, Behzad Mansoori, et al.
Clinical and Experimental Neuroimmunology (2022) Vol. 13, Iss. 4, pp. 295-301
Open Access | Times Cited: 5
Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage
Athanasios Chalkias, Ioannis Pantazopoulos, Nikolaos Papagiannakis, et al.
Toxicology Reports (2021) Vol. 8, pp. 1394-1398
Open Access | Times Cited: 6
A computational study on hydroxychloroquine binding to target proteins related to SARS-COV-2 infection
V.B. Navya, M.V. Hosur
Informatics in Medicine Unlocked (2021) Vol. 26, pp. 100714-100714
Open Access | Times Cited: 6
Cholinergic Deficiency in the Cholinergic System as a Pathogenetic Link in the Formation of Various Syndromes in COVID-19
Sergey Petrovich Lysenkov, D. V. Muzhenya, Тугуз Аминат Рамазановна, et al.
The Chinese Journal of Physiology (2023) Vol. 66, Iss. 1, pp. 1-13
Open Access | Times Cited: 2
Effect of stimulated platelets in COVID-19 thrombosis: Role of alpha7 nicotinic acetylcholine receptor
Lina Jankauskaitė, Mantas Malinauskas, Aušra Šnipaitienė
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 4
The Cholinergic and ACE-2-Dependent Anti-Inflammatory Systems in the Lung: New Scenarios Emerging From COVID-19
Martina Di Maro, Mauro Cataldi, Mariarosaria Santillo, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 5
Could Small Neurotoxins-Peptides be Expressed during SARS-CoV-2 Infection?
Concetta Cafiero, Alessandra Micera, Agnese Re, et al.
Current Genomics (2021) Vol. 22, Iss. 8, pp. 557-563
Open Access | Times Cited: 5
POSSIBLE MUTATION PATHWAYS IN SARS-CoV-2
Muhammad Torequl Islam
FARMACIA (2021) Vol. 69, Iss. 6, pp. 1001-1017
Open Access | Times Cited: 4
α7 nicotinic receptor activation mitigates herpes simplex virus type 1 infection in microglia cells
Shih‐Heng Chen, Joanne C Damborsky, Belinda C Wilson, et al.
Antiviral Research (2024) Vol. 228, pp. 105934-105934
Closed Access
Subtyping of COVID-19 samples based on cell-cell interaction in single cell transcriptomes
Kyeonghun Jeong, Yooeun Kim, Jaemin Jeon, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
New insights on the potential effect of progesterone in Covid‐19: Anti‐inflammatory and immunosuppressive effects
Hayder M. Al‐kuraishy, Thabat J. Al‐Maiahy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 11
Open Access | Times Cited: 1
The Role of the Acetylcholine System and Its Components in the Development of Post-COVID Syndromes (Review)
D. V. Muzhenya, С. П. Лысенков
Journal of Medical and Biological Research (2024), Iss. 2, pp. 240-252
Open Access
Clinical course and outcomes of critically ill COVID-19 patients in two successive pandemic waves
Athanasios Chalkias, Ioannis Pantazopoulos, Nikolaos Papagiannakis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Impact of Smoking on COVID-19 Symptoms in Non-Vaccinated Patients: A Matched Observational Study from Qatar
Mohammad Z. Haider, Amna Al-Mannai, Sally Sami Al-Sirhan, et al.
Journal of Multidisciplinary Healthcare (2022) Vol. Volume 15, pp. 531-540
Open Access | Times Cited: 1
A Tale of Two Twins: Discordant Presentation of COVID-19 in Identical Twins
Nicole Chan, Joseph I Berger, Alan Guo, et al.
Cureus (2022)
Open Access | Times Cited: 1
Nicotine exposure decreases likelihood of SARS-CoV-2 RNA expression and neuropathology in the hACE2 mouse brain but not moribundity
Ayland C. Letsinger, James M. Ward, Rick D. Fannin, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
EFFECTIVENESS IN HUMANS OF AN ANTIVIRAL DRUG BASED ON CHOLINERGIC AGONISTS WITH SPECIFIC DESIGN AND ROUTE OF ADMINISTRATION AGAINST COVID-19 SYMPTOMS IN A GROUP OF INFECTED PATIENTS VS. CONTROL GROUP
Orlando Angulo, Héctor Fabio Restrepo, José Gabriel León Higuera, et al.
(2021)
Closed Access | Times Cited: 1
CHOLINERGIC AGONISTS AGAINST COVID-19 IN HUMANS. RESULTS FROM A RANDOMIZED OPEN LABEL PILOT TRIAL
Orlando Angulo, Héctor Fabio Restrepo, José Gabriel León Higuera, et al.
(2021)
Closed Access | Times Cited: 1
EFFECTIVENESS IN HUMANS OF
Orlando Angulo, Héctor Fabio Restrepo, José Gabriel León Higuera, et al.
(2021)
Open Access | Times Cited: 1
EFFECTIVENESS IN HUMANS OF AN ANTIVIRAL DRUG BASED ON CHOLINERGIC AGONISTS WITH SPECIFIC DESIGN AND ROUTE OF ADMINISTRATION AGAINST COVID-19 SYMPTOMS IN A GROUP OF INFECTED PATIENTS VS. CONTROL GROUP
Orlando Angulo, Héctor Fabio Restrepo, José Gabriel León Higuera, et al.
(2021)
Open Access | Times Cited: 1

Scroll to top